Microneedling with bleomycin as a treatment for periungueal and subungueal warts

Morelló-Vicente, Ana; Antoñanzas, Javier; España, Agustín

doi:10.1016/j.medcli.2023.02.010

array:23 ["pii" => "S0025775323001094" "issn" => "00257753" "doi" => "10.1016/j.medcli.2023.02.010" "estado" => "S300" "fechaPublicacion" => "2023-06-23" "aid" => "6208" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2023" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Clin. 2023;160:e11-e12" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0025775323001112" "issn" => "00257753" "doi" => "10.1016/j.medcli.2023.01.025" "estado" => "S300" "fechaPublicacion" => "2023-06-23" "aid" => "6210" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2023;160:e13-e14" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "Carta al Editor" "titulo" => "Consideraciones sobre la ecografía clínica en pacientes con insuficiencia cardiaca atendidos en hospitalización a domicilio" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e13" "paginaFinal" => "e14" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Considerations for clinical ultrasound in patients with heart failure treated in home hospitalization" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Begoña Espinosa, Victor Gil, Pablo Herrero" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Begoña" "apellidos" => "Espinosa" ] 1 => array:2 [ "nombre" => "Victor" "apellidos" => "Gil" ] 2 => array:2 [ "nombre" => "Pablo" "apellidos" => "Herrero" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020623002127" "doi" => "10.1016/j.medcle.2023.01.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020623002127?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775323001112?idApp=UINPBA00004N" "url" => "/00257753/0000016000000012/v1_202306120952/S0025775323001112/v1_202306120952/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0025775323000660" "issn" => "00257753" "doi" => "10.1016/j.medcli.2023.02.004" "estado" => "S300" "fechaPublicacion" => "2023-06-23" "aid" => "6194" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Clin. 2023;160:564-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Scientific letter" "titulo" => "Role of preoperative albendazole in the treatment of primary muscular hydatidosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "564" "paginaFinal" => "565" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Papel del albendazol preoperatorio en el tratamiento de la hidatidosis muscular primaria" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 772 "Ancho" => 1340 "Tamanyo" => 103693 ] ] "descripcion" => array:1 [ "en" => "(A) Initial MRI Turbo STIR sequence on a coronal plane demonstrates a multilobed fluid-filled lesion (yellow arrows) extending from the obturator to the abductor muscles. The primary lesion appears hyperintense on T2-WI (B) and shows a peripheral enhancement on post-contrast T1-WI (C) with internal daughter lesions (yellow arrowheads). (D) After 2 months of treatment with albendazole, a reduction of the lesion (yellow arrow) is observed." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Miguel Sogbe, Cesar Urtasun, José Luis del Pozo" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Miguel" "apellidos" => "Sogbe" ] 1 => array:2 [ "nombre" => "Cesar" "apellidos" => "Urtasun" ] 2 => array:2 [ "nombre" => "José Luis" "apellidos" => "del Pozo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775323000660?idApp=UINPBA00004N" "url" => "/00257753/0000016000000012/v1_202306120952/S0025775323000660/v1_202306120952/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "Scientific letter" "titulo" => "Microneedling with bleomycin as a treatment for periungueal and subungueal warts" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e11" "paginaFinal" => "e12" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Ana Morelló-Vicente, Javier Antoñanzas, Agustín España" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Ana" "apellidos" => "Morelló-Vicente" ] 1 => array:2 [ "nombre" => "Javier" "apellidos" => "Antoñanzas" ] 2 => array:4 [ "nombre" => "Agustín" "apellidos" => "España" "email" => array:1 [ 0 => "aespana@unav.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Micropunciones de bleomicina como tratamiento para verrugas periungueales y subungueales" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1658 "Ancho" => 1505 "Tamanyo" => 158196 ] ] "descripcion" => array:1 [ "en" => "Patient 1: (a) subungueal wart before treatment and (b) after treatment. Patient 2: (c) periungueal wart before treatment and (d) after treatment." ] ] ] "textoCompleto" => "Periungual and subungual warts (P-SW) are fibroepithelial tumors of the nail unit caused by the human papillomavirus. The diagnosis is mainly clinical. Differential diagnosis with squamous cell carcinoma or Bowen's disease must be made in refractory lesions.<a class="elsevierStyleCrossRefs" href="#bib0030">1,2</a> Treatment of P-SW is a challenge because of their recurrence, treatment tolerability and efficacy<a class="elsevierStyleCrossRefs" href="#bib0040">3,4</a> and the further complication that it can lead to nail plate damage.<a class="elsevierStyleCrossRef" href="#bib0035">2</a>Bleomycin is a cytotoxic agent that inhibits DNA and protein synthesis. Satisfactory results have been reported with intralesional bleomycin treatment with concentrations ranging from 1 to 3U/mL.<a class="elsevierStyleCrossRef" href="#bib0035">2</a> Some studies have used bleomycin with a multi-puncture technique, which also provides good response.<a class="elsevierStyleCrossRef" href="#bib0045">4</a>This is a retrospective and descriptive study including five patients, 3 female and 2 male, ages 16–60 years presenting P-SW who did not respond to other treatments. The time of course of the lesions was between 8 months and 8 years. The diagnosis was made based on history and clinical features (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1A, 1C</a>).<elsevierMultimedia ident="fig0005"></elsevierMultimedia>The same method was used in all patients following the technique used for other skins lesions in our center. First, the nail plate was cut until the wart was totally exposed and 2% intralesional Mepivacaine was injected to anesthetize the area. Then, bleomycin was dropped onto the lesion at a concentration of 1.5IU/ml and multiple punctures on the wart surface with a 25-gauge 5/8 0.5×16 needle were made. Then occlusion was applied for 12h. The patients were followed-up one and three months after the treatment. Cure was defined as the total absence of the lesion.All patients achieved total remission, but the number of sessions required by each individual was different. Two patients needed one session, other two needed two sessions and only one needed three sessions. If more than one session was needed, the period of time between them was 2–4 months (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1B, 1D</a>).After the treatment, moderate pain was the major complain of the patients. There were no other local or systemic side effects reported except a slight alteration of sensation in one patient.The number of reports using microneeding technique exclusively in P-SW is scarce. Varying concentrations of bleomycin solution have been used in different studies due to the lack of standardization.<a class="elsevierStyleCrossRef" href="#bib0035">2</a>Local skin reactions after bleomycin injections include transient symptoms of erythema, edema, blackening, eschar formation, pain, and pigmentary changes. Less common adverse reactions include gangrene, onychodystrophy, Raynaud's phenomenon, scleroderma, and flagellate erythema.<a class="elsevierStyleCrossRefs" href="#bib0035">2,5</a> Contraindications for bleomycin include pregnancy, Raynaud phenomenon, peripheral vascular disease, and bleomycin intolerance.<a class="elsevierStyleCrossRef" href="#bib0050">5</a>Microneedling is a minimally invasive procedure. The microneedles penetrate the epidermis without removing it, creating micropores through the stratum corneum and into the underlying epidermis, leading to the rapid delivery of topical medications into the dermal microcirculation.<a class="elsevierStyleCrossRef" href="#bib0040">3</a>Gamil et al. compared the clinical response between microneedling with bleomycin, intralesional bleomycin and placebo in plantar warts. The best results were obtained using the microneedling technique with a complete clearance in 88.9% of the patients versus 83.3% with the intralesional treatment.<a class="elsevierStyleCrossRef" href="#bib0040">3</a> These results are consistent with those reported by Al-Naggar et al.<a class="elsevierStyleCrossRef" href="#bib0045">4</a>Di Chiacchio et al. compared treatment with intralesional bleomycin alone and followed by electroporation in ungual warts. The latter technique provided better response with a clearance of 87.7 versus 50%.<a class="elsevierStyleCrossRef" href="#bib0030">1</a>In our study, all the patients have complete response using the microneedling technique without any important side effects, with only one of the patients needing three sessions.Treatment with bleomycin using the microneedling technique offers promising results with few side effects in P-SW. During the follow-up no recurrence was recorded. Further studies are required to determine the cure rate, optimum follow-up and the therapeutic dose.Ethical considerationsWritten informed consent was obtained.FundingThe authors declare that they have no source of funding.Conflict of interestThe authors declare that they have no conflict of interest." "textoCompletoSecciones" => array:1 [ "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Ethical considerations" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Funding" ] 2 => array:2 [ "identificador" => "sec0015" "titulo" => "Conflict of interest" ] 3 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1658 "Ancho" => 1505 "Tamanyo" => 158196 ] ] "descripcion" => array:1 [ "en" => "Patient 1: (a) subungueal wart before treatment and (b) after treatment. Patient 2: (c) periungueal wart before treatment and (d) after treatment." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ungual warts: comparison of treatment with intralesional bleomycin and electroporation in terms of efficacy and safety" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "N.G. Di Chiacchio" 1 => "N. Di Chiacchio" 2 => "P.R. Criado" 3 => "C.H.M. Brunner" 4 => "M.V.R. Suaréz" 5 => "W. Belda Junior" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jdv.15815" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2019" "volumen" => "33" "paginaInicial" => "2349" "paginaFinal" => "2354" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31314920" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of intralesional bleomycin in the management of ungual warts" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Singal" 1 => "G. Chander" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ski Appendage Disord" "fecha" => "2020" "volumen" => "6" "paginaInicial" => "346" "paginaFinal" => "350" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combined therapy of plantar warts with topical bleomycin and microneedling: a comparative controlled study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "H.D. Gamil" 1 => "M.M. Nasr" 2 => "F.M. Khattab" 3 => "A.M. Ibrahim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/09546634.2019.1612837" "Revista" => array:5 [ "tituloSerie" => "J Dermatol Treat" "fecha" => "2020" "volumen" => "31" "paginaInicial" => "235" "paginaFinal" => "240" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intralesional bleomycin injection vs microneedling-assisted topical bleomycin spraying in treatment of plantar warts" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.R. Al-Naggar" 1 => "A.S. Al-Adl" 2 => "A.R. Rabie" 3 => "M.R. Abdelkhalk" 4 => "M.L. Elsaie" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Cosmet Dermatol" "fecha" => "2019" "volumen" => "18" "paginaInicial" => "124" "paginaFinal" => "128" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and tolerability of intralesional bleomycin in dermatology: a systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L. Bik" 1 => "T. Sangers" 2 => "K. Greveling" 3 => "E. Prens" 4 => "M.H. Dmsc" 5 => "M. Van Doorn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2020.02.018" "Revista" => array:5 [ "tituloSerie" => "J Am Dermatol" "fecha" => "2020" "volumen" => "83" "paginaInicial" => "888" "paginaFinal" => "903" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00257753/0000016000000012/v1_202306120952/S0025775323001094/v1_202306120952/en/main.assets" "Apartado" => array:4 [ "identificador" => "66447" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas científicas" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00257753/0000016000000012/v1_202306120952/S0025775323001094/v1_202306120952/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775323001094?idApp=UINPBA00004N"]

ISSN: 0025-7753

Launched in 1943, Medicina Clínica is a fortnightly journal aimed at the promotion of clinical research and practice among internal medicine and other specialists. The key characteristics of Medicina Clínica are the scientific and methodological rigor of its manuscripts, the topicality of its contents, and, especially, its practical focus with highly useful information for clinical practice. Medicina Clínica is predominantly interested in publishing original research manuscripts, which are rigorously selected according to their quality, originality, and interest, and also in continued medical education-oriented manuscripts, which are commissioned by the journal to relevant authors (Editorials, Reviews, and Diagnosis and Treatment). These manuscripts contain updated topics with a major clinical or conceptual relevance in modern medicine. The journal adheres to the standards of academic research publications in all aspects including peer-review and ethical principles. Medicina Clínica is included in the General and Internal Medicine category of Thomson Reuters.

See more Open Access Option

Indexed in:

Current Contents/Clinical Medicine, Journal Citation Reports, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, MEDES, PASCAL, SCOPUS, ScienceDirect

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.371

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.511

View more metrics

Journal Information

Previous article | Next article

Vol. 160. Issue 12.